The Src/PLC/PKC/MEK/ERK signaling pathway is involved in aortic smooth muscle cell proliferation induced by glycated LDL

Molecules and Cells

Volumn 19, Issue 1, 2005, Pages 60-66

  Cho, Hyun Mi ^a   Choi, Sung Hee ^b   Hwang, Ki Chul ^c   Oh, Sue Young ^a   Kim, Ho Gyung ^a   Yoon, Deok Hyo ^a   Choi, Myung Ae ^a   Lim, SoYeon ^c   Song, Heesang ^c   Jang, Yangsoo ^c   Kim, Tae Woong ^a  

^a Kangwon National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Glycation; Low Density Lipoprotein; Proliferation; Smooth Muscle Cell; Src Kinase

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CHELATING AGENT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLYCOSYLATED PROTEIN; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; 4 AMINO 5 (4 METHYLPHENYL) 7 (TERT BUTYL)PYRAZOLO(3,4 D)PYRIMIDINE; 4-AMINO-5-(4-METHYLPHENYL)-7-(TERT-BUTYL)PYRAZOLO(3,4-D)PYRIMIDINE; FLAVONOID; GLYCOSYLATED LIPOPROTEINS, LDL; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PYRAZOLE DERIVATIVE; PYRIMIDINE DERIVATIVE;

AORTA MEDIA; ARTICLE; ATHEROSCLEROSIS; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; DIABETES MELLITUS; DRUG INHIBITION; HUMAN; IN VIVO STUDY; PHOSPHORYLATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; ANIMAL; AORTA; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CELL LINE; CELL PROLIFERATION; FLAVONOIDS; LIPOPROTEINS, LDL; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHOLIPASE C; PHOSPHORYLATION; PROTEIN KINASE C; PYRAZOLES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SRC-FAMILY KINASES;

EID: 22844436841     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Anand-Apte, B. and Zetter, B. (1997) Signaling mechanisms in growth factor-stimulated cell motility. Stem Cells 15, 259-267.
2. Andres, V. (1998) Control of vascular smooth muscle cell growth and its implication in atherosclerosis and restenosis. Int. J. Mol. Med. 2, 81-89.
3. Bjorkerud, B. and Bjorkerud, S. (1996) Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Atherioscler. Thromb. Vasc. Biol. 16, 416-424.
4. Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., and Vlassara, H. (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA 90, 6434-6438.
5. Choi, J. H., Bae, S. S., Park, J. B., Ha, S. H., Song, H., et al. (2003) Cbl Competitively inhibits epidermal growth factor-induced activation of phospholipase C-g1. Mol. Cells 15, 245-255.
6. Deigner, H. P. and Claus, R. (1996) Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells. FEBS Lett. 385, 149-153.
7. 5 integrins upon smooth muscle cell migration. J. Biol. Chem. 276, 41832-41840.
8. Brownlee, M., Cerami, A., and Vlassara, H. (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315-1321.
9. Ha, H., Kamanna, V., Kirschenbaum, M., and Kim, K. (1997) Role of glycated low density lipoprotein in mesangial extracellular matrix synthesis. Kidney Int. Suppl. 60, S54-S59.
10. Hwang, K. C., Lee, K. H., and Jang, Y. (2002) Epigallocatechin-3-gallate inhibits basic fibroblast growth factor-induced intracellular signaling transduction pathway in rat aortic smooth muscle cells. J. Cardiovasc. Pharmacol. 39, 271-277.
11. Ishi, H., Koya, D., and King, G. L. (1998) Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J. Mol. Med. 76, 21-31.
12. Jenkins, A. J., Velarde, V., Klein, R. L., Joyce, K. C., Phillips, K. D., et al. (2000) Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes 49, 2160-2169.
13. Karin, M. (1994) Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr. Opin. Cell Biol. 6, 415-424.
14. Klein, R. L., Laimins, M., and Lopes-Virella, M. F. (1995) Isolation, characterization, and metabolism of the glycated and non-glycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes 44, 1093-1098.
15. Kobayashi, K., Watanabe, J., Umeda, F., Masakado, M., Ono, Y., et al. (1995) Metabolism of oxidized glycated low-density lipoprotein in cultured bovine aortic endothelial cells. Horm. Metab. Res. 27, 356-362.
16. Koya, D. and King, G. L. (1998) Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859-866.
17. Krishnamurti, U., Rondeau, E., Sraer, J.-D., Michael, A. F., and Tsilibary, E. C. (1997) Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J. Biol. Chem. 272, 27966-27970.
18. Kusuhara, M., Chait, A., Cader, A., and Berk, B. C. (1997) Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages. Atherioscler. Thromb. Vasc. Biol. 17, 141-148.
19. Lewis, T. S., Shapiro, P. S., and Ahn, N. G. (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49-139.
20. Lyons, T. J., Li, W., Wells-Knecht, M. C., and Joki, R. (1994) Toxicity of mildly modified low-density lipoproteins to cultured retinal capillary endothelial cells and pericytes. Diabates 3, 1090-1095.
21. Mansour, S. J., Matten, W. T., Hermann, A. S., Candia, J. M., Rong, S., et al. (1994) Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-970.
22. Pages, G., Lenormand, P., L'Allemain, G., Chambard, J. C., Meloche, S., et al. (1993) Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90, 8319-8323.
23. Robert, Z., Ute, P., Andrea, W., Sanja, L. F., Wolfugang, G., et al. (2001) Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages. Diabates 50, 1643-1653.
24. Robinson, M. J. and Cobb, M. H. (1997) Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol. 9, 180-186.
25. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809.
26. Ruderman, N. B. and Haudenschild, C. (1984) Diabetes as an atherogenic factor. Prog. Cardiovasc. Dis. 26, 373-412.
27. Scapoli, L., Ramos-Nino, M. E., Martinelli, M., and Mossman, B. T. (2004) Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23, 805-813.
28. Schnaper, H. W. (1998) Cell signal transduction through the mitogen-activated protein kinase pathway. Pediatr. Nephrol. 12, 790-795.
29. Steve, A. M. and George, E. D. (2000) Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis sensitive tumor cell lines. Proc. Natl. Acad. Sci. USA 97, 13009-13014.
30. Sundberg, L. J., Galante, L. M., Bill, H. M., Mack, C. P., and Taylor, J. M. (2003) An endogenous inhibitor of focal adhesion kinase blocks Racl/JNK but not Ras/ERK-dependent signaling in vascular smooth muscle cells. J. Biol. Chem. 278, 29783-29791.
31. Teupser, D., Thiery, J., Walli, A. K., and Seidel, D. (1996) Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim. Biophys. Acta 1303, 193-198.
32. Tomlinson, D. R. (1999) Mitogen-activated protein kinases as glucose transducers for diabetic complications. Diabetologia 42, 1271-1281.
33. Velarde, V., Jenkins, A. J., Christopher, J., Lyons, T. J., and Jaffa, A. A. (2001) Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J. Appl. Physiol. 91, 1412-1420.
34. Watson, M. H., Venance, S. L., Pang, S. P., and Mak, A. S. (1993) Smooth muscle cell proliferation. Expression and kinase activities of p34cdc2 and mitogen-activated protein kinase homologues. Circ. Res. 73, 109-117.
35. Yang, G. Y., Yao, J. S., Huey, M., Hashimoto, T., and Young, W. L. (2004) Participation of PI3K and ERK1/2 pathways are required for human brain vascular smooth muscle cell migration. Neurochem. Int. 44, 441-446.
36. Zhang, J., Ren, S., Sun, D., and Shen, G. X. (1998) Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Atherioscler. Thromb. Vasc. Biol. 18, 1140-1148.